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Abstract
The family Picornaviridae is a large and diverse group of viruses that infect humans and animals. 
Picornaviruses are among the most common infections of humans and cause a wide spectrum of 
acute human disease. This study began as an investigation of acute flaccid paralysis (AFP) in a 
small area of eastern Bolivia, where surveillance had identified a persistently high AFP rate in 
children. Stools were collected and diagnostic studies ruled out poliovirus. We tested stool 
specimens from 51 AFP cases and 34 healthy household or community contacts collected during 
2002–2003 using real-time and semi-nested RT-PCR assays for enterovirus, parechovirus, 
cardiovirus, kobuvirus, salivirus, and cosavirus. Anecdotal reports suggested a temporal 
association with neurologic disease in domestic pigs, so six porcine stools were also collected and 
tested with the same set of assays, with the addition of an assay for porcine teschovirus. A total of 
126 picornaviruses were detected in 73 of 85 human individuals, consisting of 53 different 
picornavirus types encompassing five genera (all except Kobuvirus). All six porcine stools 
contained porcine and/or human picornaviruses. No single virus, or combination of viruses, 
specifically correlated with AFP; however, the study revealed a surprising complexity of enteric 
picornaviruses in a single community.
Introduction
Picornaviruses are among the most common viruses infecting humans. Enteroviruses (EV), 
including EV species A to D, and rhinovirus species A to C, are the most thoroughly 
characterized human picornaviruses and cause a wide spectrum of acute clinical disease, 
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including undifferentiated febrile illness, respiratory illness, aseptic meningitis, and acute 
flaccid paralysis (AFP). Human parechoviruses (HPeV) have a similar disease spectrum as 
the EVs, but routine clinical testing is less common despite increasing evidence of a 
significant disease burden in infants (Harvala et al., 2010). Zoonotic infection with 
encephalomyocarditis virus (EMCV) has been reported (Oberste et al., 2009) but testing for 
this virus is rarely performed in human clinical virology laboratories. No routine testing is 
available for newer human picornaviruses, which include Saffold viruses (SAFV) 
(Cardiovirus), cosaviruses (CoSV) (also published as “dekavirus”; Cosavirus), and 
“salivirus” (SALV) (also published as “klassevirus”; Salivirus) (Adams et al.; Knowles et 
al., 2012).
AFP is a manifestation of many different disease processes with different mechanisms, and 
multiple causes, both infectious and non-infectious, including paralytic poliomyelitis, certain 
arboviruses, Guillain-Barré syndrome (GBS), transverse myelitis, certain toxins, and trauma. 
Surveillance for AFP is recommended by the World Health Organization (WHO) as the 
standard approach for poliovirus surveillance for the purposes of Global Polio Eradication 
(Anonymous, 2006). A wide variety of non-polio enteroviruses and other picornaviruses 
have been identified in stool specimens of AFP cases (Bingjun et al., 2008; Kapoor et al., 
2001; Kapoor et al., 2008; Oberste et al., 2006; Saeed et al., 2007; Santos et al., 2002; Shoja 
et al., 2007). Detection of high-prevalence agents from a non-sterile site is not sufficient to 
conclusively establish an etiologic link of picornavirus infection with disease; however, 
given the known ability of many picornaviruses to cause central nervous system (CNS) 
disease, it is likely that these viruses contribute to at least a fraction of AFP cases. From 
1996 to 2006, AFP surveillance activities in Bolivia identified persistently high AFP rates in 
Hernando Siles province, Chuquisaca Department, a relatively poor, largely agricultural area 
in southern Bolivia. These unusually high AFP rates—40 to 140 per 100,000 children under 
age 15, compared to 1.2 to 2.3 per 100,000 for Bolivia as a whole—have raised considerable 
local public concern. In all cases, wild poliovirus has been ruled out by laboratory testing 
through the routine AFP surveillance program (Anonymous, 2006); environmental 
contamination of water and effects of agricultural chemicals were also ruled out. There were 
anecdotal reports of concurrent outbreaks of paralytic illness in local pigs, though no direct 
evidence linking human and porcine diseases was available.
The plausibility of a picornavirus etiology and the availability of archived fecal specimens 
presented an opportunity to assess the role of non-polio picornaviruses in pediatric AFP and 
the diversity of enteric picornaviruses in children in rural Bolivia.
Results
A total of 49 AFP cases (32 from Chuquisaca, and 17 from Santa Cruz) and 32 contacts (17 
from Chuquisaca and 15 from Santa Cruz) were included in the clinical analyses. Of the 49 
AFP cases, 26 were reported in 2002 and 23 in 2003. Detailed clinical and epidemiologic 
information was available for 45 cases. The median age of cases was 5 years (range, 1–21 
years) with >90% occurring among children aged ≤8 years; 19 (42%) were male. There was 
significant geographic difference in seasonality, as all cases from Chuquisaca had onset 
during February-May, while cases from Santa Cruz were distributed throughout the year, 
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with February to May accounting for 58.8% (10 cases) (p < 0.001). Most (33 or 75.0%) of 
the 44 cases for whom available clinical details were sufficient for classification presented 
with GBS-like paralysis, one case (2.3%) had enterovirus/polio-like paralysis and 10 cases 
(22.7%) had a mixed clinical picture (Table 1). Clinical presentations of AFP cases in both 
departments were comparable.
All of the human stools collected were analyzed for picornaviruses (N = 85 total; 51 AFP 
and 34 contacts). At least one picornavirus was detected in specimens of 73 (85.9%) study 
subjects, including 37 apparent coinfections with >1 picornavirus, with evidence of up to six 
different viruses (five different picornaviral genera) in a single patient (Table 2). There were 
no significant differences between virus detection rates by case/contact status or between 
departments, suggesting that picornavirus infection was not associated with AFP in these 
cases. Nevertheless, the study presented an opportunity to examine the diversity of enteric 
picornaviruses in this population.
Picornaviruses detected in human stools included members of the Enterovirus, 
Parechovirus, Cardiovirus, Salivirus, and Cosavirus genera (Tables 2 and 3). EVs were 
detected in 44 specimens, representing 19 different types from three different EV species 
(Table 3; Figure 1). Members of EV-A, including coxsackievirus (CV) A5, CVA14, EV76, 
and EV90, were identified in nine instances (Figure 1E). Nine specimens yielded EV-B, 
including echovirus (E) 1, E24, E29, E30, E33, and EV106 (Figure 1C). Poliovirus vaccine 
strains, commonly found in pediatric fecal samples in countries that use live-attenuated, oral 
polio vaccine, were detected in two samples, one PV2 and one PV3. Other EV-C viruses 
were also detected, including CVA1, CVA11, CVA17, CVA20, CVA24, EV96, and EV113 
(22 detections) (Figure 1B). In two cases, VP1 sequences appeared to be mixtures of EVs 
and the individual sequences could not be resolved. Two additional specimens were 5’NTR 
real-time positive with high Ct values near the limit of detection, and negative with the 
confirmatory/typing EV VP1 assay.
Sixteen human specimens yielded seven types of human parechoviruses (HPeV), including 
HPeV1, HPeV2, HPeV3, HPeV4, HPeV7, HPeV9, and HPeV12 (Tables 2 and 3; Figure 
2A). HPeV4 was the most common HPeV (four human specimens), followed by HPeV7 and 
HPeV9. The Bolivia HPeV1 VP1 sequences were most closely related to the HPeV1 
prototype strain Harris/USA-1956 (84% nucleotide identity [%NT ID] and 95% amino-acid 
identity [% AA ID]), unlike most recent HPeV1s, which have split into a separate HPeV1 
clade (Figure 2A). The two HPeV2 strains from Bolivia are most closely related to the 
HPeV2 prototype strain Williamson/USA-1956 (86% NT ID and 96% AA ID). Notably, the 
Bolivia HPeV4 VP1 carboxyl-termini lacked the RGD motif found in all other HPeV4s in 
GenBank (data not shown), and had instead a variant consensus carboxyl-terminal end (17 
amino-acids). We were unable to grow these variant HPeV4s in cell culture, unlike the 
prototype HPeV4 that grows readily in Vero and other cell types. The Bolivia HPeV4s 
shared six identical amino acids at the putative VP1-2A cleavage site (NPFEDE / S) and 
significant amino acid similarity in the remainder of the carboxyl-tail (data not shown) with 
HPeV1 and HPeV5 variants from the Netherlands and with HPeV15 from Bangladesh 
(Oberste et al., 2013). The single HPeV3 found in Bolivia also lacked the RGD motif. We 
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did not attempt to grow this virus in culture. HPeV1s and HPeV2s found in Bolivia all 
contained the RGD motif.
Cardiovirus was detected in 21 human specimens (Table 2), including 16 detections of 
members of the species Theilovirus, and five detections of members of the 
Encephalomyocarditis virus (EMCV) species. Partial VP1 sequencing was successful for 11 
of 16 theilovirus-positive specimens and all were identified as SAFV (Table 3; Figure 2B). 
SAFV1 was the most common type identified, with five positive stools, followed by 
SAFV2, SAFV9, and SAFV4 (Figure 2B). Phylogenetically, SAFV1s split into two Bolivia 
clades, sharing 87.9 to 89.1% NT ID between them (99.1 to 100 % AA ID). Both clades had 
from 77.3 to 79.2 % NT ID (94.4 to 95.8 % AA ID) with the 1981 SAFV1 prototype strain 
from the United States (NC009448). The two SAFV2 strains clustered with SAFV2 from 
Brazil. One SAFV sequence appeared to be a mixture and four other specimens were SAFV 
5’NTR real-time positive, but negative in the SAFV VP1 assay. All EMCV-positive 
specimens had very high threshold cycle (Ct) values (from 40 to 45) near the limit of 
detection (Ct of 45), indicating very low genome copy number, and could not be 
independently confirmed with the EMCV VP1 sequencing/typing assay.
Human cosaviruses (CoSV) were detected in 44 human stool specimens (Ct values from 30 
to 44.7), 35 of which yielded clean partial VP1 sequences (Tables 2 and 3, Figure 3A–E). 
Five CoSV sequences appeared to be mixtures, which could not be resolved and four 
specimens with high CoSV real-time Ct values were not amplified by the CoSV VP1 
sequencing assay. Three CoSVs were typed as CoSV A3 (77 to 85.2% NT ID and 93.2 to 
100% AA ID), three as CoSV A8 (76–94.5% NT ID and 88–97.6% AA ID), two as CoSV 
A17 (78.8–90% NT ID and 93.4–98.2% AA ID), one as CoSV A7 (77.9% NT ID and 95% 
AA ID) and two as CoSV D4 (80–99.5% NT ID and 88.5–90.7% AA ID). CoSV species A 
was the most common CoSV detected (15 viruses; eleven types), followed by CoSV E (13 
viruses; nine types), CoSV D (six viruses; three types), and CoSV B (one virus). Analysis of 
the partial VP1 sequences of the Bolivia CoSVs suggests that 22 of them can be classified as 
15 new types (nine CoSV E, three CoSV A, two CoSV D and one CoSV B). All of their 
partial VP1 sequences have <75% NT ID and <88% AA ID to all previously characterized 
CoSV types (Holtz et al., 2008; Kapoor et al., 2008).
A single specimen was positive by 5’NTR real-time RT-PCR targeting human kobuvirus 
and salivirus but not canine, murine, porcine or bovine kobuviruses (in silico analyses only) 
(Tables 2 and S1), with the partial VP1 sequence having 79.8% NT ID (88% AA ID) to the 
prototype SALV A1 (GQ507022) and 92.4% NT ID (96% AA ID) to a candidate SALV A2 
(JQ898343) from Thailand (2009), sequenced directly from sewage (Ng et al., 2012). Based 
on the partial VP1 sequence analyses, all three of these viruses are SALV A1. None of the 
human specimens tested positive for teschovirus.
Picornaviruses were detected in all six pig specimens (Table 2). Partial VP1 sequences from 
two of these were porcine enteroviruses (PEV) (Figure 1D), one of which may represent a 
new PEV type, having only 73% NT ID (76% AA ID) to the closest PEV in GenBank 
(GQ502355), while the other PEV shared 78% NT ID (86% AA ID) with PEV-10 
(GQ502355). Parechovirus was detected in three pig specimens; two were identified as 
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HPeV4 (Figure 2A), but the third (Ct = 38.6) produced no VP1 amplicon, so the type could 
not be determined. One cardiovirus of TMEV species was detected (Ct = 38), but VP1 
sequence could not be obtained. CoSV with a partial VP1 sequence that was a close match 
to a Bolivia CoSV sequence from a human specimen (98.9% NT ID and 97.6% AA ID) was 
detected in one pig stool (Figure 3B). Teschovirus was detected and identified in three of six 
pigs with no further characterization. No human kobuviruses or saliviruses were detected in 
the pigs. Four picornaviruses were detected in a single pig, including teschovirus, PEV (Ct = 
25), CoSV (Ct = 42.5), and HPeV4 (Ct = 35.4).
The four human and one porcine HPeV4 with complete VP1 sequences were 97 to 100% NT 
ID (97.4 to 100% AA ID) to one another and 73.0 to 73.9% NT ID (84.1 to 85.8% AA ID) 
to the HPeV4 prototype (AM235750). With <75% NT ID and <88% AA ID to the HPeV4 
prototype, the Bolivia HPeV4s could possibly be classified as a new type (Nix et al., 2010); 
however, most of the difference between the prototype and the Bolivia HPeV4s was due to 
variation in 17 amino acids (51 nucleotides) at the carboxyl-terminal end. When these 17 
amino acids were omitted from the analysis, the Bolivia HPeV4s were 89.3 to 91.1% AA ID 
(75.9 to 76.8% NT ID) to the HPeV4 prototype strain.
Discussion
Our study demonstrates that picornavirus diversity in human and animal feces is clearly 
much more complex than previously known. Nevertheless, our findings suggest that 
picornaviruses are not a major contributor to the very high AFP rates observed in the 
Hernando Siles province of Bolivia. The basis for this conclusion includes the predominance 
of GBS-like presentation usually not consistent with picornavirus etiology, tremendous 
diversity of identified picornaviruses without any predominant agents, substantial overlap of 
results between cases and contacts, or between clinical subtypes, and lack of significant 
differences between the departments with high and low incidence. The involvement of 
picornaviruses in individual cases cannot be ruled in or out based on the available data.
Molecular methods detect a wider range of picornaviruses than cell culture alone (Begier et 
al., 2008) and several of the picornaviruses found in this study have not been cultured to 
date (CoSV, SALV, and new HPeV types), thereby confirming the superior performance of 
molecular approaches for surveillance, diagnostics, and genotyping of picornaviruses. 
Several other studies, using both classical and molecular methods, have detected EV, HPeV, 
SAFV, and CoSV in fecal samples from AFP cases (Bingjun et al., 2008; Junttila et al., 
2007; Kapoor et al., 2001; Oberste et al., 2006; Saeed et al., 2007). Most previous studies, 
including our own, used specific PCR assays to detect members one or two genera (usually 
only Enterovirus), due to specificity, low cost, and potential for high throughput, though 
some investigators are starting to use metagenomics methods to expand the range of viruses 
that can be detected (Victoria et al., 2009), with limitations of higher per-sample cost and 
lower overall throughput. Our approach was a compromise between specific PCR and 
metagenomics, allowing the possibility of detecting seven different genera within the family 
Picornaviridae. In areas where conditions are favorable for fecal-oral transmission, one 
should expect to find a wide variety of enteric picornaviruses. As metagenomic approaches 
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become more cost effective, a wider range of potential pathogens can be detected in large 
studies, facilitating better assessment of disease association.
A diverse range of EVs was identified in this study (Figure 1), including 19 different types, 
among them a newly identified type, EV-C113, which along with EV-A90 were the most 
common viruses identified in the study, and another recently discovered type, EV-B106. Of 
the four EV species EV-C was the most common. No EV-D viruses were identified.
Our study also demonstrated substantial diversity of HPeVs in Bolivia (Figure 2A). One of 
the seven different types identified had a distinct genetic characteristic, specifically, the 
absence of the classical RGD integrin-binding motif, shown to be the receptor ligand for 
HPeV1 and possibly the receptor ligand for HPeV2, 4, 5, and 6 as well. This is distinct from 
all other previously described HPeV4, but similar to HPeV3 and HPeVs 7 through 16, which 
lack the RGD motif in all VP1 sequences published to date (Benschop et al., 2008). The 
absence of the RGD motif in these viruses suggests that these viruses may interact with 
integrins by a different mechanism or use a different receptor altogether. The carboxyl-
terminal differences between the HPeV4 prototype and the Bolivia viruses may be the result 
of intertypic recombination and another HPeV. Natural intertypic recombination at the 3’ 
end of the P1 region has been reported for polioviruses (Blomqvist et al., 2003; Blomqvist et 
al., 2010).
Very few human clinical virology laboratories are capable of testing for cardiovirus. With 
the exception of the recent reports of SAFV (TMEV species) in human feces and respiratory 
specimens (Abed & Boivin, 2008; Drexler et al., 2011; Drexler et al., 2008; Jones et al., 
2007; Nielsen et al.; Zoll et al., 2009), almost all cardiovirus testing is for animal specimens 
in the context of EMCV epizootics (Maurice et al., 2005). Recent studies have reported 
EMCV infection in two human cases from Peru (Oberste et al., 2009) and 21% EMCV 
seroprevalence among persons sampled in the same area of Peru (Czechowicz et al., 2011). 
Both cardiovirus species were identified in Bolivia human samples. All EMCV-positive 
specimens in our study had very high Ct values approaching the assay’s limit of detection 
(Ct of 45 or approximately 10 EMCV genomic copies), suggesting a very low viral load and 
no type data was acquired from these specimens. The low levels of EMCV detected may be 
indicative of environmental contamination with rodent materials, resulting in “pass-through” 
virus and not indicative of virus replication in the human intestinal tract. SAFV1, the most 
common cardiovirus genotype identified (Figure 2B), was the overall third most common 
virus found among study subjects. SAFV2, detected in North and South America, Europe, 
and Asia, has been the most commonly identified genotype to date (Abed & Boivin, 2008; 
Blinkova et al., 2009; Chiu et al., 2008; Drexler et al., 2008; Itagaki et al., 2010; Zoll et al., 
2009). SAFV2 has been associated with respiratory disease (Abed & Boivin, 2008; Chiu et 
al., 2008), and with invasive disease, including two fatalities (Drexler et al., 2011; Nielsen 
et al.). All SAFV types have been associated with gastroenteritis, often in coinfections with 
other known viral pathogens. Additional studies are needed to determine the prevalence of 
SAFV and zoonotic EMCV infection in humans, define the associations with human 
disease, and to estimate the human disease burden due to cardioviruses.
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CoSV, found in a large proportion of study subjects, were equal to EV in prevalence. 
Quantitative real-time RT-PCR showed high CoSV viral load in stool, ranging from 
approximately 4 × 104 to 4 × 109 per gram stool (data not shown), indicating probable CoSV 
replication in the intestinal tract. CoSV diversity, based on partial VP1 sequences, was the 
broadest of all picornavirus genera identified, encompassing 21 types in CoSV-A, -B, -D, 
and -E (Table 3; Figure 3). Picornavirus typing using partial VP1 sequences is generally 
reliable; however, because the ICTV Picornavirus Study Group requires at least complete 
VP1 sequence for consideration of new types, the new CoSV types from Bolivia must be 
considered tentative until complete VP1 sequences have been acquired. These studies are in 
progress.
A single salivirus, SALV A1 was identified in the Bolivia samples. SALV A1 has not been 
isolated in culture, and represents the only definitive type identified so far worldwide. SALV 
seroprevalence in the United States, investigated using an IgG ELISA, was 8.6% in a 
pediatric cohort and 21.8% in an adult cohort (Greninger et al., 2009), suggesting infection 
is relatively common.
The inclusion of pig specimens was related to anecdotal reports of frequent paralytic illness 
in pigs in communities with high human AFP rates. Three pig illnesses which are associated 
with encephalitis and can present with paralysis have been repeatedly documented in the 
area: pseudorabies (Aujeszky’s disease), caused by porcine herpesvirus 1; classical swine 
fever, caused by a flavivirus; and Teschen-Talfan disease, caused by teschoviruses 
(Anonymous, 2011; 2012a; b; World Organization for Animal Health). None of these 
viruses infects humans but, because people in these communities often have very high 
exposure to pigs due to their economic importance, potential zoonotic transmission of other 
porcine viruses (e.g. EMCV) must be considered. Our study did not identify porcine viruses 
in any of the human specimens. However, we detected carriage of human picornaviruses, 
including HPeV, CoSV, and SAFV, in pigs. The HPeV4 and CoSV found in pig specimens 
were clearly the same respective viruses found in the human specimens (Figure 2A–B, and 
3B) but the possibility of human picornavirus replication in the pigs can only be 
systematically addressed through animal studies. Though the study is limited by the amount 
and quality of clinical and epidemiologic data available for diseased pigs and the small 
number of specimens, the data suggest zoonotic porcine picornaviruses are an unlikely cause 
of the disease in humans
The limitations of this study include lack of true controls as only contacts of AFP cases were 
tested, which are likely to share exposures, and consequently viral flora, with cases. In 
addition, stool is not the optimal specimen for picornavirus disease association studies due 
to the high proportion of asymptomatic infections and because disease generally affects 
other organ systems. The zoonotic transmission aspect of the study was limited by the lack 
of clinical and epidemiologic data for the pigs and the small number of specimens.
The cause of very high AFP rates in Hernando Siles province of Chuquisaca Department in 
Bolivia remains unclear, but most likely is not due to picornavirus infections. A potential 
non-infectious cause worth additional exploration could be the toxins from Karwinskia 
plants common in Central and South America. The K. humboldtiana fruits contain toxins 
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known to cause GBS-like illness, and their consumption has been associated with relatively 
high rates of AFP in some Central American countries (Martinez et al., 1998; Ocampo-
Roosens et al., 2007). A representative of Karwinskia genus, K. oblongifolia grows in this 
area of Bolivia (Serrano & Terán, 2000) and its fruit is commonly consumed by children.
Materials and Methods
Study subjects
AFP cases and their contacts from Hernando Siles province reported to the national AFP 
surveillance system during 2002–2003 were included in the study. Hernando Siles is a poor, 
difficult to access, agricultural region with mountainous terrain, a subtropical climate, and a 
population of approximately 36,000 (~0.4% of the national population, 34.6% aged <15 
years; 2001 census, http://apps.ine.gob.bo/censo/entrance.jsp). Most people live in isolated 
communities established in river canyons and in the towns of Huacareta and Monteagudo, 
the provincial capital. Available specimens from AFP cases and their contacts from Santa 
Cruz Department in eastern Bolivia, which does not have a high AFP rate, were tested for 
comparison.
Clinical and epidemiologic data for the AFP cases were obtained from national AFP 
surveillance records during a 2007 site visit. Details for the contacts of cases were not 
available. The available clinical data were limited because of the lack of specialist neurology 
examinations for all but two cases and the absence of imaging or nerve conduction studies to 
confirm the diagnosis and further characterize the subtype of AFP. Additionally, no 
cerebrospinal fluid was taken for laboratory examination or virus diagnostic studies. Clinical 
subtypes of AFP were classified as GBS-like, enterovirus/poliovirus-like, and “mixed.” 
Cases with ascending, symmetric, more distal than proximal paralysis which progressed 
over several days and often had sensory involvement were considered as having GBS-like-
paralysis. Cases with descending, asymmetric, more proximal than distal paralysis were 
considered as having EV/polio-like paralysis. Cases with features of both categories were 
classified as having a “mixed” subtype. Chi-square and Fisher’s test were used for statistical 
comparisons, as appropriate.
Specimen collection
Stool specimens included in the study were collected from AFP cases and their household or 
community contacts by the Ministry of Health, aided by PAHO-Bolivia, following World 
Health Organization guidelines for AFP case investigation (Anonymous, 2006). 
Additionally, six fecal specimens were collected from domestic pigs in the affected 
communities in Hernando Siles.
Picornavirus molecular detection and identification
RNA was extracted from stool suspensions, as previously described (Nix et al., 2006), and 
tested for enterovirus, parechovirus, cardiovirus, kobuvirus, salivirus, and cosavirus by 
genus- or genus/species-specific Taqman® real-time RT-PCR assays targeting the 5’ non-
translated region (5’NTR) (Kilpatrick et al., 2009; Nix et al., 2008; Oberste et al., 2009) 
(Table S1). Teschovirus testing was performed by using a 5’-NTR nested RT-PCR (Zell et 
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al., 2000), with the addition of PCR amplicon sequencing to confirm the identity of the 
correct-sized PCR product.
In vitro transcribed single-stranded RNA controls were produced from PCR products as 
described previously (Nix et al., 2008). RNA control transcripts were used to generate 
standard curves for estimating genome copy numbers in the stool specimens. RT-PCR 
primers and the viral RNAs used to make DNA templates for the in vitro RNA transcription 
reactions are shown in Table S2.
Real-time PCR-positive specimens were confirmed by nested or semi-nested RT-PCR 
targeting a portion of the genome encoding the VP1 capsid protein (S3–S6), followed by 
amplicon sequencing for EV (Nix et al., 2006), HPeV (Nix et al., 2010), cardiovirus 
(Oberste et al., 2009), kobuvirus, salivirus, and cosavirus. Virus type was determined by 
comparison of the VP1 amplicon nucleotide sequences with VP1 sequences of the reference 
strains for each genus by script-driven sequential pairwise comparison using the program 
Gap (Wisconsin Sequence Analysis Package, version 11.0, Accelrys, Inc., San Diego, CA). 
Deduced VP1 amino acid sequences were compared by a similar method. VP1 nucleic acid 
sequences were aligned using the Pileup program (Wisconsin Package) and phylogenetic 
relationships were inferred by the neighbor-joining method implemented in MEGA, version 
4.0 (Kumar et al., 2001), using the Kimura 2-parameter method (Jones et al., 1992; Kumar 
et al., 2001). Support for specific tree topologies was estimated by bootstrap analysis with 
1000 pseudo-replicate data sets. Nucleotide and amino acid identity matrices were 
calculated using MegAlign (DNAStar, version 8, Madison, WI).
The nucleotide sequences described here have been deposited in the GenBank sequence 
database, accession no. JX219484-JX219590. Four nucleotide sequences used to identify 
virus types were rejected by GenBank due to their short lengths (<200 base pairs) (Table 
S9).
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Figure 1. 
Phylogenetic relationships among human enteroviruses detected in Hernando Siles province. 
The VP1 nucleic acid tree was constructed by the neighbor-joining method implemented in 
MEGA, version 4, using the Kimura 2-parameter substitution model (Jones et al., 1992) and 
1000 bootstrap pseudoreplicates. E, echovirus; EV, enterovirus; CV, coxsackievirus. A. The 
radial tree shows the distribution of EV species (EV-A, -B, -C, -D, and porcine EV-G) typed 
from Bolivia (filled circles). B-E. Subtrees of EV-C, EV-B, EV-G, and EV-A respectively. 
Chuquisaca: solid circle = AFP case, hollow circle = contact, hollow triangle = porcine; 
Santa Cruz: solid square = AFP case, hollow square = contact. Prototype viruses detected in 
Bolivia are in bold. Only full length, double-stranded partial VP1 sequences were included 
for phylogenetic analyses.
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Figure 2. 
A. Phylogenetic relationships among human parechoviruses detected in Hernando Siles 
province. B. Phylogenetic relationships among human cardioviruses detected in Hernando 
Siles province. The VP1 nucleic acid trees were constructed by the neighbor-joining method 
implemented in MEGA, version 4, using the Kimura 2-parameter substitution model (Jones 
et al., 1992) and 1000 bootstrap pseudoreplicates. Chuquisaca: solid circle = AFP case, 
hollow circle = contact, hollow triangle = porcine; Santa Cruz: solid square = AFP case, 
hollow square = contact. Prototype viruses detected in Bolivia are in bold. Only full length, 
double-stranded partial VP1 sequences were included for phylogenetic analyses.
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Figure 3. 
Phylogenetic relationships among human cosaviruses (CoSV) detected in Hernando Siles 
province. The VP1 nucleic acid tree was constructed by the neighbor-joining method 
implemented in MEGA, version 4, using the Kimura 2-parameter substitution model (Jones 
et al., 1992) and 1000 bootstrap pseudoreplicates. A. The radial tree shows the distribution 
of CoSV species (CoSV-A, -B, -D, and -G) typed from Bolivia (filled circles). B-E. Subtrees 
of CoSV-A, -B, -D, and -E respectively. Chuquisaca: solid circle = AFP case, hollow circle 
= contact, hollow triangle = porcine; Santa Cruz: solid square = AFP case, hollow square = 
contact. All proposed prototype CoSVs are shown in bold. Only full length, double-stranded 
partial VP1 sequences were included for phylogenetic analyses.
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Table 1
Clinical characteristics of AFP cases from Chuquisaca and Santa Cruz departments, Bolivia, 2002–2003.
Characteristics N (%)
Duration of progression, mean (range) 6 (1–15) days
Ascending paralysis 33/43 (76.7%)
Descending paralysis 2/43 (4.7%)
Simultaneous paralysis in all 4 limbs 8/43 (18.6%)
Symmetric paralysis 36/43 (83.7%)
Paresthesias 5/24 (20.8%)
Sensory deficits 19/30 (63.3%)
Muscle pain 36/40 (90.0%)
Febrile/”infectious” prodrome 24/43 (55.8%)
Fever at paralysis onset 20/43 (46.7%)
Residual paralysis/weakness (>70 days
after onset) 28/43 (65.1%)
Death 2/43 (4.7%)
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